JPM
JPMorgan Chase & Co.
JPM has a slight edge over TCBX overall, supported by stronger fundamentals and stronger modeled upside.
TCBX
Third Coast Bancshares, Inc.
TCBX offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
TCBX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
TCBX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like TCBX.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
TCBX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.7x | $39.68 | — |
| Cheap | 9.9x | $38.58 | -2.8% |
| Current | 10x | $39.68 | — |
| Fair | 11x | $41.75 | +5.2% |
| Expensive | 12x | $47.55 | +20% |
Historical ranges are pointers, not guarantees.
TCBX has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over TCBX on the outlook, with more favorable profitability expectations.
TCBX Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TCBX, but weaker profitability.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
TCBX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.09 | +4.6% |
| Q3 2026 | $3.91 | +9.5% |
| Q2 2026 | $4.01 | +22% |
| Q1 2026 | $3.89 | +32% |
| Q4 2025 | $3.79 | +36% |
| Q3 2025 | $3.57 | +39% |
| Q2 2025 | $3.28 | +53% |
| Q1 2025 | $2.95 | +45% |
| Q4 2024 | $2.78 | +40% |
TCBX has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over TCBX on profitability, with a higher operating margin.
TCBX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $65.9M | +21% |
| Q2 2026 | $68M | +31% |
| Q1 2026 | $57.7M | +26% |
| Q4 2025 | $56.5M | +22% |
| Q3 2025 | $54.5M | +27% |
| Q2 2025 | $52M | +25% |
| Q1 2025 | $45.9M | +14% |
| Q4 2024 | $46.3M | +17% |
TCBX has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | -5.8 points |
| Q2 2026 | 40% | 0 points |
| Q1 2026 | 33% | -4.9 points |
| Q4 2025 | 38% | -0.6 points |
| Q3 2025 | 42% | +4 points |
| Q2 2025 | 40% | +6.4 points |
| Q1 2025 | 38% | +5.8 points |
| Q4 2024 | 39% | +8.4 points |
TCBX's operating margin was 36% last quarter, down 5.8 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
TCBX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.9M | -57% |
| Q2 2026 | $45M | +224% |
| Q1 2026 | -$38.7M | -469% |
| Q3 2025 | $20.7M | -5.8% |
| Q2 2025 | $13.9M | +90% |
| Q1 2025 | $10.5M | +11% |
| Q3 2024 | $22M | +1077% |
| Q2 2024 | $7.3M | -22% |
TCBX has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over TCBX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
TCBX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +101K shares |
| 1 year | +18% | +3M shares |
| 3 years | +21% | +3.6M shares |
TCBX has 20M diluted shares, up 18% from a year ago.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
TCBX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.0x | Net Cash |
| Q2 2026 | -3.6x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -2.5x | Net Cash |
| Q4 2024 | -4.9x | Net Cash |
TCBX has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
TCBX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.3 | Neutral |
| Stochastic | 7.5 | Oversold |
TCBX's weekly RSI is 43 (neutral) and its Stochastic is 8 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
TCBX PE vs Financial Services Sector
| Metric | TCBX | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 22% below |
| PE % | 26 | 64 | 38 pts below |
TCBX has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over TCBX on trend strength, trading above more of its moving averages.
TCBX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.9 | 3.1% below |
| 20 week MA | $42.6 | 6.7% below |
| 50 week MA | $40.6 | 2.3% below |
| 100 week MA | $37.7 | 5.2% above |
| 200 week MA | $29.1 | 36% above |
TCBX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 36% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over TCBX on returns for 2026, with the stronger performance.
TCBX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $25.1 | $25.9 | +3.3% |
| 2022 | $25.9 | $18.5 | -28% |
| 2023 | $18.5 | $19.9 | +7.2% |
| 2024 | $19.9 | $34.1 | +72% |
| 2025 | $34.1 | $39.4 | +15% |
| 2026 YTD | $39.4 | $39.7 | +0.7% |
TCBX has finished higher in four of the last five years. It's up 0.7% so far in 2026.